Editorial: Beyond borders: exploring diverse roles of heterocyclic compounds in combatting infections and cancer

Afzal B. Shaik; Richie R. Bhandare; M. Mukhlesur Rahman; Kamal Dua

doi:10.3389/fchem.2025.1578852

Editorial: Beyond borders: exploring diverse roles of heterocyclic compounds in combatting infections and cancer

Afzal B. Shaik
, Richie R. Bhandare
, M. Mukhlesur Rahman
, Kamal Dua

Vignan's Foundation for Science, Technology & Research
Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
Ajman University
University of East London
University of Technology Sydney

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

This Research Topic aimed to explore the advancements and applications of heterocyclic compounds, highlighting their importance in contemporary medicinal chemistry. The objective was to examine their diverse roles in tackling two major health concerns: infectious diseases and cancer. Currently, cancer and infectious diseases are among the most prevalent and challenging health conditions, significantly affecting the overall wellbeing of the population. According to the World Health Organization (WHO), approximately 20 million new cancer cases were diagnosed globally in 2022, with 9.7 million deaths attributed to the disease. Projections suggest that by 2050, the number of cancer cases could rise to 35 million (Seigel et al., 2023).

Original language	English
Article number	1578852
Number of pages	4
Journal	Frontiers in Chemistry
Volume	13
DOIs	https://doi.org/10.3389/fchem.2025.1578852
Publication status	Published - Mar 2025
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

anti-infective agents
anticancer agents
bioactive heterocyclic compounds
computational chemistry
drug design
medicinal chemistry
natural product chemistry
synthesis and semisynthesis

Access to Document

10.3389/fchem.2025.1578852Licence: CC BY

Full textFinal published version, 526 KBLicence: CC BY

Cite this

@article{2a4d56a738e6417daa239e47f16d6cc5,

title = "Editorial: Beyond borders: exploring diverse roles of heterocyclic compounds in combatting infections and cancer",

abstract = "This Research Topic aimed to explore the advancements and applications of heterocyclic compounds, highlighting their importance in contemporary medicinal chemistry. The objective was to examine their diverse roles in tackling two major health concerns: infectious diseases and cancer. Currently, cancer and infectious diseases are among the most prevalent and challenging health conditions, significantly affecting the overall wellbeing of the population. According to the World Health Organization (WHO), approximately 20 million new cancer cases were diagnosed globally in 2022, with 9.7 million deaths attributed to the disease. Projections suggest that by 2050, the number of cancer cases could rise to 35 million (Seigel et al., 2023). ",

keywords = "anti-infective agents, anticancer agents, bioactive heterocyclic compounds, computational chemistry, drug design, medicinal chemistry, natural product chemistry, synthesis and semisynthesis",

author = "Shaik, \{Afzal B.\} and Bhandare, \{Richie R.\} and Rahman, \{M. Mukhlesur\} and Kamal Dua",

year = "2025",

month = mar,

doi = "10.3389/fchem.2025.1578852",

language = "English",

volume = "13",

journal = "Frontiers in Chemistry",

issn = "2296-2646",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - Beyond borders: exploring diverse roles of heterocyclic compounds in combatting infections and cancer

AU - Shaik, Afzal B.

AU - Bhandare, Richie R.

AU - Rahman, M. Mukhlesur

AU - Dua, Kamal

PY - 2025/3

Y1 - 2025/3

N2 - This Research Topic aimed to explore the advancements and applications of heterocyclic compounds, highlighting their importance in contemporary medicinal chemistry. The objective was to examine their diverse roles in tackling two major health concerns: infectious diseases and cancer. Currently, cancer and infectious diseases are among the most prevalent and challenging health conditions, significantly affecting the overall wellbeing of the population. According to the World Health Organization (WHO), approximately 20 million new cancer cases were diagnosed globally in 2022, with 9.7 million deaths attributed to the disease. Projections suggest that by 2050, the number of cancer cases could rise to 35 million (Seigel et al., 2023).

AB - This Research Topic aimed to explore the advancements and applications of heterocyclic compounds, highlighting their importance in contemporary medicinal chemistry. The objective was to examine their diverse roles in tackling two major health concerns: infectious diseases and cancer. Currently, cancer and infectious diseases are among the most prevalent and challenging health conditions, significantly affecting the overall wellbeing of the population. According to the World Health Organization (WHO), approximately 20 million new cancer cases were diagnosed globally in 2022, with 9.7 million deaths attributed to the disease. Projections suggest that by 2050, the number of cancer cases could rise to 35 million (Seigel et al., 2023).

KW - anti-infective agents

KW - anticancer agents

KW - bioactive heterocyclic compounds

KW - computational chemistry

KW - drug design

KW - medicinal chemistry

KW - natural product chemistry

KW - synthesis and semisynthesis

UR - https://www.scopus.com/pages/publications/105000504733

U2 - 10.3389/fchem.2025.1578852

DO - 10.3389/fchem.2025.1578852

M3 - Article

AN - SCOPUS:105000504733

SN - 2296-2646

VL - 13

JO - Frontiers in Chemistry

JF - Frontiers in Chemistry

M1 - 1578852

ER -

Editorial: Beyond borders: exploring diverse roles of heterocyclic compounds in combatting infections and cancer

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this